Gerber Kawasaki Wealth & Investment Management Prothena Corp Public LTD CO Transaction History

Gerber Kawasaki Wealth & Investment Management

$2.16 Billion
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2021 Feb 11, 2022	SELL	$42.11 - $73.26 $42 - $73	-1 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$48.2 - $78.89 $48 - $78	1 New	1 $1,000

Others Institutions Holding PRTA

# of Institutions

184

Shares Held

42.7M

Call Options Held

162K

Put Options Held

102K

Eco R1 Capital, LLC San Francisco, CA

11.6M
Shares

$158 Million
8.41% of portfolio
Wellington Management Group LLP Boston, MA

4.18M
Shares

$57.1 Million
0.01% of portfolio
Black Rock Inc. New York, NY

3.86M
Shares

$52.7 Million
0.0% of portfolio
Price T Rowe Associates Inc Baltimore, MD

3.82M
Shares

$52.3 Million
0.01% of portfolio
Palo Alto Investors LP Palo Alto, CA

1.74M
Shares

$23.8 Million
4.0% of portfolio

View Full List

About PROTHENA CORP PUBLIC LTD CO

Ticker PRTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,922,800
Market Cap $641M
Description
Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...

More about PRTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gerber Kawasaki Wealth & Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Gerber Kawasaki Wealth & Investment Management with notifications on news.

Account